Corporate
  • Astellas Pharma

    Created in 2005
  • Social networks

    509,818 42,723 42,723
  • Sectors

  • Location

    Nihombashi Astellas Mitsui Bldg., 2-chōme-5-1 Nihonbashihonchō, Chuo City, Tokyo 103-0023, Japan

    Chuo City

    Japan

  • Engaged entities

    107
    72 22
  • Added in Motherbase

    17 Jul 2024, 2:43 p.m.
Description
  • Value proposition

    Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world.

    At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

    Pharmaceuticals and 医薬品

Entity interactions BETA
Entity TypeTweets Articles
ISTUD Business School ISTUD Business School
Higher Education, edtech
Other

12 Dec 2023


Global Health Innovative Technology (GHIT) Fund Global Health Innovative Technology (GHIT) Fund
deeptech, healthtech, Non-profit Organizations
Other

21 Aug 2024


Astellas Gene Therapies Astellas Gene Therapies
biotech, deeptech, Biotechnology Research
Other

31 May 2023


PredictBy PredictBy
deeptech, Research Services
Other

31 Oct 2022


ArisGlobal ArisGlobal
Software Development
Other

18 Apr 2023


Future Planet Future Planet
greentech, cleantech, Environmental Services
Other

17 May 2024


DeepMirror DeepMirror
edtech, it services, Biotechnology Research
Other

31 May 2024


MIP Discovery MIP Discovery
biotech, manufacturing, deeptech, Biotechnology Research
Other

31 Jan 2024


Market Study Report Market Study Report
Market Research
Other

27 Dec 2023


European Pharmaceutical Manufacturer European Pharmaceutical Manufacturer
Book and Periodical Publishing
Other

31 Jan 2023


Radars
Loading...